Geisinger Medical Laboratories Test Catalog

Order Display Name: Geisinger Epic Procedure Code Or ID CPT Code:  


Geisinger Epic Procedure Code: LAB3709             Geisinger Epic ID: 29277

Specimen type:
Bone marrow, whole blood
Preferred collection container:
Alternate Collection Container:
Bone marrow culture transport media
Specimen required:
3 mL bone marrow (minimum 1 mL) collected in heparin syringe. Place the bone marrow in green top sodium heparin tube during off-shifts. 10 mL whole blood (minimum 1 mL) collected in sodium heparin tube.
Special notes:
Clinical history and reason for referral are required with test order. Previous bone marrow transplant or therapy information, if applicable, should be provided with test order.

Transport temperature:
Room temperature.
Specimen stability:
Transport immediately after collection. Viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Rejection criteria:
Frozen specimens unacceptable.

Additional information:
This test may be replaced by one of the following if the completed test cannot be performed from the submitted specimen: a Tissue Culture for Hematologic Disorder code; or with a Cytogenetics Communication, if a communication is required.
CPT code(s):
88237, 88264
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
CHROMOSOME BONE MARROW OR BLOOD, Myelodysplastic Syndrome (MDS),Myeloproliferative Disorders (MPD),Acute Lymphoblastic Leukemia (ALL),Chronic Myelogenous Leukemia (CML),Philadelphia Chromosome
KARYOTYPE, HEMCR, Quest test code 14600
Clinical significance:
Chromosome Analysis, Hematologic Malignancy - Cytogenetics of hematologic disorders attempts to define and interpret chromosomal aberrations that occur in neoplastic cells associated with leukemia, lymphoma and other hematologic malignancies. Chromosome abnormalities in cancer cells of patients with malignant hematologic disorders including acute and chronic myeloid and lymphoid leukemias, myelodysplastic and myeloproliferative disorders, lymphomas and unexplained anemias may correlate with the diagnosis, prognosis, treatment and etiology of disease.

Performing Locations

Quest Diagnostics

Technical Lead: Michael Weaver    
Frequency: Set-up: Monday-Saturday morning. Report available: 8 days.    
Performed STAT? No
Locations  |    Search  |    Site Map |   Contact Us
©2000-2024 Geisinger Health System.   All rights reserved.